Name
Amprion
Company Description
Amprion is the global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing. Amprion’s intellectual property surrounding SAA methodology extends to research, drug development, and commercialization. SAAmplify-ɑSYN biomarker test (formerly SYNTap®) is the only seed amplification assay available to aid the diagnosis of synucleinopathies associated with Parkinson’s disease, Lewy body dementia, and Alzheimer’s disease with Lewy body co-pathology. Amprion is also accelerating precision medicine for neurodegenerative disorders by helping biopharma partners identify new drug candidates and underlying pathologies.
Website
Categories (6)
Aging and Dementia, Aging, Dementia, Cognitive, and Behavior, Alzheimer's/Other Dementias, Behavioral and Cognitive Neurology, Movement Disorders, Parkinson's Disease, Sleep Disorders, Other